8491 (8491) Fair Value & Analysis

Consumer Defensive · Market cap HK$122M

8 8491 8491 · HK

PriceHK$0.3050

Fair ValueHK$0.0900

Upside-70.5%

Quality39/100

Watch 8491 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.0700 – HK$0.1200

Fair value as of: Jul 3, 2026

From 11 valuation models · updated today

Share price −11.6% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2850 – HK$0.6300 · fair‑value band HK$0.0700 – HK$0.1200 · the HK$0.3050 price screens above the HK$0.0900 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8491 (8491) currently trades at HK$0.3050, while our model-based Fair Value estimate is HK$0.0900 — implying the stock looks roughly 70.5% overvalued today. We read business quality at 39/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 8491 generated revenue of HK$29.4M at a net margin of -5.5%. Revenue grew 2.4% year over year. It earns a return on equity of -7.3%. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) HK$29.4M

Revenue growth (YoY) +2.4%

Net margin -5.5%

Return on equity -7.3%

Free cash flow HK$1.4M FY2025

Operating margin -11.3%

More key figures

EPS growth (YoY) +3,713%

Net debt HK$298K FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

8491 reported revenue of HK$29.4M in FY2025 versus HK$32.8M in FY2021, a compound −2.7%/yr. Reported net income was −HK$1.6M in FY2025.

Revenue −2.7%/yr

FY21 HK$32.8M

FY22 HK$34.7M

FY23 HK$30.8M

FY24 HK$29.5M

FY25 HK$29.4M

Net income

FY21 −HK$1.2M

FY22 −HK$8.7M

FY23 −HK$1.1M

FY24 −HK$4.2M

FY25 −HK$1.6M

Is 8491 fairly valued? → Check now

Similar stocks

6 more Food Distribution stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock	Price	Fair Value	vs Fair Value
Sysco Corporation SYY	$78.54	$39.26	-50%
US Foods Holding USFD	$90.18	$48.56	-46%
Performance Food Group PFGC	$102.61	$49.97	-51%
Jerónimo Martins, SGPS, S.A JRONF	$23.70	$24.02	+1%
JMT JMT	75.60 PLN	85.48 PLN	+13%
Bunzl plc BZLFY	$16.36	$19.41	+19%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 8491 (8491) undervalued?

As of Jul 3, 2026, our model estimates a fair value of HK$0.0900 versus a price of HK$0.3050 — about −70% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 8491?

Our model-based fair value for 8491 is HK$0.0900 (as of Jul 3, 2026), built from audited fundamentals. The current price is HK$0.3050.

What is the quality score of 8491?

8491 has a Quality Score of 39/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 8491 (8491)?

8491 reported trailing-twelve-month revenue of about HK$29.4M (latest available figure, as of Jul 3, 2026).

What is the net profit margin of 8491?

The net profit margin of 8491 is about -5.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.